OFI Invest Asset Management Acquires Shares of 2,645 Integer Holdings Co. (NYSE:ITGR)

OFI Invest Asset Management purchased a new position in Integer Holdings Co. (NYSE:ITGR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,645 shares of the medical equipment provider's stock, valued at approximately $338,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Janney Montgomery Scott LLC raised its stake in Integer by 2.6% in the third quarter. Janney Montgomery Scott LLC now owns 9,668 shares of the medical equipment provider's stock valued at $1,257,000 after purchasing an additional 246 shares in the last quarter. Legacy Capital Wealth Partners LLC raised its position in shares of Integer by 92.1% during the 3rd quarter. Legacy Capital Wealth Partners LLC now owns 3,688 shares of the medical equipment provider's stock valued at $479,000 after buying an additional 1,768 shares in the last quarter. Crossmark Global Holdings Inc. lifted its holdings in shares of Integer by 14.7% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,899 shares of the medical equipment provider's stock worth $377,000 after acquiring an additional 372 shares during the last quarter. State of New Jersey Common Pension Fund D grew its position in Integer by 1.8% in the third quarter. State of New Jersey Common Pension Fund D now owns 15,582 shares of the medical equipment provider's stock worth $2,026,000 after acquiring an additional 268 shares in the last quarter. Finally, Versor Investments LP increased its stake in Integer by 48.0% in the third quarter. Versor Investments LP now owns 3,404 shares of the medical equipment provider's stock valued at $443,000 after acquiring an additional 1,104 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of equities analysts have recently issued reports on ITGR shares. Citigroup upped their price objective on Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a report on Wednesday, December 11th. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. KeyCorp lifted their price target on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Finally, Benchmark lifted their target price on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Integer has an average rating of "Moderate Buy" and an average target price of $147.67.

Integer Trading Down 0.5 %

Shares of Integer stock traded down $0.64 during trading on Friday, reaching $117.76. 2,991,416 shares of the stock were exchanged, compared to its average volume of 369,482. Integer Holdings Co. has a 1 year low of $107.11 and a 1 year high of $146.36. The firm has a market cap of $3.96 billion, a price-to-earnings ratio of 35.05, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The stock's fifty day moving average is $134.43 and its 200 day moving average is $132.75.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. As a group, equities research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.